Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone
Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone is a medicine authorised by Swissmedic under authorisation number 67774. The authorisation holder is Bailleul (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 April 2021 and the authorisation is valid without a time limit. ATC code D07CC01 places the medicine in the group Corticosteroids, dermatological preparations.
| Authorisation number | 67774 |
|---|---|
| Name | Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone |
| Full name | Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone, Crème |
| Authorisation holder | Bailleul (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D07CC01 |
| First authorisation | 13 April 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone, Crème | B | 13 April 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 15 | g | D07CC01 | 10.05.2. | B |
| 2 | 30 | g | D07CC01 | 10.05.2. | B |
| 3 | 60 | g | D07CC01 | 10.05.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone authorised in Switzerland?
Yes. Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone is authorised by Swissmedic under authorisation number 67774, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone have?
Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone?
The authorisation holder is Bailleul (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.